These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 25885682)

  • 1. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice.
    Latta CH; Sudduth TL; Weekman EM; Brothers HM; Abner EL; Popa GJ; Mendenhall MD; Gonzalez-Oregon F; Braun K; Wilcock DM
    J Neuroinflammation; 2015 Mar; 12():41. PubMed ID: 25885682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice.
    Weekman EM; Sudduth TL; Abner EL; Popa GJ; Mendenhall MD; Brothers HM; Braun K; Greenstein A; Wilcock DM
    J Neuroinflammation; 2014 Jul; 11():127. PubMed ID: 25062954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
    Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
    J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice.
    McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA
    Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
    Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
    J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
    Wu PJ; Hung YF; Liu HY; Hsueh YP
    Neuroimmunomodulation; 2017; 24(1):29-39. PubMed ID: 28618410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.
    Fu W; Vukojevic V; Patel A; Soudy R; MacTavish D; Westaway D; Kaur K; Goncharuk V; Jhamandas J
    J Neuroinflammation; 2017 Oct; 14(1):199. PubMed ID: 28985759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice.
    Unger MS; Schernthaner P; Marschallinger J; Mrowetz H; Aigner L
    J Neuroinflammation; 2018 Sep; 15(1):274. PubMed ID: 30241479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model.
    Park TS; Ryu YK; Park HY; Kim JY; Go J; Noh JR; Kim YH; Hwang JH; Choi DH; Oh WK; Lee CH; Kim KS
    Int J Mol Med; 2017 Jan; 39(1):21-30. PubMed ID: 28004107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation.
    Cherry JD; Olschowka JA; O'Banion MK
    J Neuroinflammation; 2015 Nov; 12():203. PubMed ID: 26538310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
    van Groen T; Miettinen P; Kadish I
    J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
    J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine attenuates glial activation and proinflammatory cytokines in APP/PS1 transgenic mice via inhibition of nuclear factor-κB pathway.
    Zhu S; Shi R; Li V; Wang J; Zhang R; Tempier A; He J; Kong J; Wang JF; Li XM
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25618401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation.
    Gallagher JJ; Minogue AM; Lynch MA
    Neurodegener Dis; 2013; 11(1):33-41. PubMed ID: 22627185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
    Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
    Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.
    Rojanathammanee L; Floden AM; Manocha GD; Combs CK
    J Neuroinflammation; 2015 Mar; 12():42. PubMed ID: 25889879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.